1
4/20/2021
Curriculum Vitae Hani A. Kushlaf, MD, FAAN, FANA, FAANEM
1. PERSONAL DATA
Business address:
Department of Neurology & Rehabilitation Medicine 260 Stetson St. Suite 2300 PO Box 670525 Cincinnati, OH 45219-0525 Phone: 513-558-5197 Fax: 513-558-4305 Email: [email protected]
2. EDUCATION Medical School:
10/1/95-5/2002 University of Tripoli Medical School (Formerly known as Al Fateh University, Faculty of Medicine), Tripoli, Libya.
Additional education:
7/2017- 12/15/2018 University of Cincinnati Post-Baccalaureate Certificate Program in Clinical and Translational Research
1/2021-Present University of Cincinnati Master of Science in Clinical & Translational Research - Principal Investigator (MSCTR-PI) track
Residencies/Fellowships:
7/2011-6/2012 Fellow, Advanced Neuromuscular Medicine Fellowship, Duke University Medical Center, Durham, NC Program Director: Vern Juel, MD
6/2010-6/2011 Fellow, Peripheral Nerve Fellowship, Mayo Clinic, Rochester, Minnesota Program Director: James P. Dyck, MD
7/2009-6/2010 Fellow, Muscle Disease Fellowship, Mayo Clinic, Rochester, Minnesota Program Director: Andrew G. Engel, MD
7/2008-6/2009 Chief Resident, Department of Neurology, University of Kentucky, Lexington, Kentucky. Chairman: Joseph Berger, MD, Program director: Michael Dobbs, MD
7/2006-6/2008 Resident, Department of Neurology, University of Kentucky hospital,
2
Lexington, Kentucky. Chairman: Joseph Berger, MD, Program director: Michael Dobbs, MD
7/2005-6/2006 Intern, Department of internal medicine, University of Kentucky hospital, Lexington, Kentucky.
Additional training:
9/23-9/24/2020 TREAT-NMD EXPERT Masterclass on Limb Girdle Muscular Dystrophy (LGMD)
2/8-2/22/2017 NeuroNEXT Site Principal Investigator Training Webinars
1/14/2016 NEALS (NorthEast Amyotrophic Lateral Sclerosis Consortium) Site Investigator Training at Massachusetts General Hospital in Boston, MA
10/2-10/3/2014 Investigator training program workshop at the University of Cincinnati
8/3-8/9/2008 American Neurological Association, First Annual Summer Course for Clinical and Translational Investigators in Neurology and Neuroscience, Park City, Utah
Board Certifications:
2019 Diplomate of the American Board of Electrodiagnostic Medicine (ABEM)- Neuromuscular Ultrasound Certificate of Added Qualification#23 (Permanent)
2015 Diplomate of the United Council of Neurologic Subspecialties-Clinical Neuromuscular Pathology #17
2013 Diplomate of the American Board of Electrodiagnostic Medicine (ABEM) #3667
2011 Diplomate of the American Board of Psychiatry and Neurology-Neuromuscular Medicine #391
2009 Diplomate of the American Board of Psychiatry and Neurology (ABPN) #55737- Recertified 12/15/2019
2005 Diplomate of the Educational Commission for Foreign Medical Graduates (ECFMG) #06574966 (permanent)
Medical Licensure:
2012 -Present Ohio License#099883
2011-5/26/2013 North Carolina Training License
2009-5/31/2012 Minnesota License # 52277
2005-2009 Kentucky Training License# R1175- Residency License
3
3. ACADEMIC APPOINTMENTS
7/10/2020-Present Research Director, Neuromuscular Division
10/23/2018-Present Neuromuscular Neurologist at the Comprehensive Neuromuscular Center at Cincinnati Children’s Hospital and Medical Center
9/1/2017-Present Associate Professor of Neurology & Pathology Neuromuscular Division Department of Neurology & Rehabilitation Medicine and Department of Pathology & Laboratory Medicine University of Cincinnati
7/1/2018-Present Director of the UC Muscular Dystrophy Association (MDA) Care Center
9/2016-6/30/18 Assistant Director of the UC Muscular Dystrophy Association (MDA) Care Center
11/2013-Present UCMC/UCCOM Neuromuscular Medicine Fellowship Director
9/1/2012-8/31/17 Assistant Professor of Neurology & Pathology Neuromuscular Division Department of Neurology & Rehabilitation Medicine and Department of Pathology & Laboratory Medicine University of Cincinnati
9/1/2012-Present Neuromuscular Neurologist at the University of Cincinnati Gardner Neuroscience Institute (UCGNI)/Medical Arts Building
9/1/2012-12/31/2018 Neuromuscular Neurologist at UC Health West Chester North Physician’s Office
9/1/2012-Present Neuromuscular Neurologist at the UC Muscular Dystrophy Clinic
9/1/2012-6/30/2015 Clinical Neurophysiology fellowship teaching faculty
4. AWARDS AND HONORS
2021 Castle Connolly Top Doctors
2020 Cincy Best Docs by CincyMagazine (Finalist in Neurology)
2020 Alpha Omega Alpha (AOA) Honor Medical Society
2020 America’s Most Honored Doctors (The American Registry)
2020 Castle Connolly Top Doctors
4
2020 Vitals Patients’ Choice Award
2020 Vitals On-Time Doctor Award
2020 Vitals Compassionate Doctor Recognition
2019/2020 Ohio Magazine Top Neurologist
2019 Marquis Who’sWho in America
2019 America’s Most Honored Professionals (The American Registry)
2019 Castle Connolly Top Doctors
2018 Fellow of the American Neurological Association (FANA)
2018 Fellow of the American Academy of Neurology (FAAN)
2018 America’s Most Honored Professionals
2018 Vitals Patients’ Choice Award
2018 Vitals Compassionate Doctor Recognition
2018 Vitals On-Time Doctor Award
2018 Castle Connolly Top Doctors
2017 Castle Connolly Top Doctors
2017 President’s Research Initiative Award, American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
2015 Vitals On-Time Doctor Award
2014 Next Generation Biomedical Investigator Award “10 K” for research career development
2013 Fellow, American Association of Neuromuscular and Electrodiagnostic Medicine (FAANEM)
2012 Junior Member Recognition Award, American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
2009 Resident scholarship from the American Academy of Neurology (AAN) to attend the annual AAN meeting in Seattle, Washington
2009 Resident scholarship to attend Kiffen Penry epilepsy mini-fellowship at Wake Forest University
2009 Departmental resident travel award to attend the AAN meeting in Seattle for the highest Residency In-service Training Examination (RITE) score in the US
2008 Departmental resident travel award to attend the American Neurological Association (ANA) summer course for the highest RITE score in the neurology residency
5
Program
2008 Vitals Patients’ Choice Award
2008 Chief Resident, University of Kentucky, Department of Neurology, Lexington, KY
2008 Outstanding Resident of the Month Award, University of Kentucky Chandler Medical Center, Lexington, Kentucky
2007 American Neurological Association (ANA) resident scholarship award to attend the ANA meeting in Washington, DC
2002 Ranked 1st among medical school class at The University of Tripoli Medical School, Tripoli, Libya
5. MEMBERSHIPS IN PROFESSIONAL ORGANIZATIONS
2020-Present Member, Alpha Omega Alpha (AOA) Honor Medical Society 2018-Present Fellow of the American Neurological Association (ANA) 2015-Present Member of the NorthEast Amyotrophic Lateral Sclerosis (NEALS) Consortium 2008-Present Fellow of the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) 2007-Present Fellow, American Academy of Neurology (AAN), neuromuscular,
neurogenetics, clinical neurophysiology, A.B. Baker neurologic education,
and spine sections
2005-2009 Founding member, Commonwealth of Kentucky Neurological Society
2009-2011 Minnesota Medical Association
2009-2011 American Medical Association
6. SERVICE:
8/2020 MDA Engage Ohio Community Education Virtual Seminar- Talk title “Research and Clinical Trial Review and Updates”
5/2020 Abstract Reviewer, American Neurological Association Annual Meeting
4/2019 Abstract Reviewer, American Neurological Association Annual Meeting
6
3/2019 Abstract Reviewer, UCGNI research day
2/26/2019 Neurology on the Hill, Amercian Academy of Neurology (AAN)
12/1/2018 Regional MDA Care Center Director Meeting at Nationwide Children’s Hospital in Columbus, OH
10/27/2018 Ohio Regional Myasthenia Gravis Foundation of America (MGFA) Conference-Talk title “Novel therapies in Myasthenia Gravis”
10/20/2018 Organization Committee, Myotonic Dystrophy Day Regional Conference at Cincinnati Children Hospital & Medical Center
9/8/2018 Southern Ohio MDA-Myasthenia Gravis Support Group-talk titled “The Complement System in Myasthenia Gravis”
3/2018 Abstract Reviewer, UCGNI research day
3/11/2018 MDA Care Center Director meeting in Arlington, VA
11/2017-1/2018 Prospective MD student shadowing (David Youssef)
9/2017 American Board of Electrodiagnostic Medicine (ABEM) board prep course at the AANEM annual meeting
3/2017 UCGNI research day abstract reviewer
2/2017 Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD) Center ALS grant review
10/22/2016 MDA Care Center 2017 grant application reviewer
9/10/2016 Southern Ohio MDA-Myasthenia Gravis Support Group- talk titled “Myasthenia Gravis Update”
11/24/15-Present Department of Neurology & Rehabilitation Medicine Scheduling Task Force
2013-Present Physician on-call coverage for the Annual Muscular Dystrophy Association Camp
Committees and Councils:
4/2021-Present Member, International Myositis Assessment & Clinical Studies Group (IMACS)
11/2019-Present Member, Accreditation Council on Graduate Medical Education (ACGME)
Neuromuscular Medicine Milestone 2.0 Workgroup (National)
9/2018-Present Member, University of Cincinnati Center for Continuous Professional Development Advisory Committee (CCPD)
7
6/2018-Present Member, UC Health Conflict of Interest Review Committee 5/2018-Present Member, American Board of Electrodiagnostic Medicine Continuous Certification Committee (National) 5/2018-Present Member, Medical/Scientific Advisory Board of the Myasthenia Gravis Foundation of America (MGFA) (National) 2016-2020 Member, AANEM NM Self-Assessment Committee (National)
2015-Present Clinical Competency Committee- UC Neuromuscular Medicine Fellowship
2015-Present Program Evaluation Committee- UC Neuromuscular Medicine Fellowship
2013-2016 Member, AANEM EDX Self-Assessment Committee (National)
2013-Present UC GME Program Director Committee
2013-Present UC neuromuscular pathology QA Committee- Monthly meetings
Editorial Board
1/2021-Present Muscle& Nerve
Ad hoc Reviewer
2017-Present Journal of Clinical Neuromuscular Disease (1-2 manuscripts per year)
2016-Present Muscle & Nerve (9-10 manuscripts per year)
2016-Present Clinical Diabetes (1 manuscript per year)
2015- Present Canadian Journal of Neurological Sciences (1-2 manuscripts per year)
2013- Present Diabetes (1-2 manuscripts per year)
7. TEACHING
11/2013-Present UCMC/UCCOM Neuromuscular Medicine fellowship director
Fellows trained Year of training Position after fellowship
Ikjae Lee, MD 2015-2016 Assistant Professor of Neurology at Columbia University. New York, NY Nassima Baba- 2016-2017 Assistant Professor of Ahmed, MD Neurology at the University of Wisconsin-Madison
9/1/2012-6/30/2015 Clinical Neurophysiology fellowship teaching faculty
8
2013-2017 UC Neuroscience educational pathway mentor Student: Douglas Dembinski
2020-Present MSSP Program (Mentoring medical students in Neuroscience)
Mentoring:
1. Janecek J, Kushlaf H. Toxin-induced channelopathies, neuromuscular junction disorder, and myopathy. Neurologic clinics (published). Mentored Dr. Jacqueline Janecek (PGY4 chief resident) during all stages of preparation and writing the manuscript.
2. Jacqueline Janecek, Hani Kushlaf. Myopathy predominant presentation caused by the c.1360 C>T desmin pathogenic variant. Accepted for presentation at the annual AANEM virtual meeting. 10/8/2020. Mentored Dr. Jacqueline Janecek (PGY4 chief resident) during all stages of preparing the abstract and poster presentation. Dr. Jacqueline Janecek received the AANEM Resident & Fellow Recognition Award for this abstract.
1. Assia Meziane-Tani, Hani Kushlaf. Axonal Charcot-Marie-Tooth disease caused by a novel YARS variant. AANEM annual meeting in Austin, Texas. 10/18/2019. Mentored Dr. Meziane-Tani (PGY2 resident) during all stages of preparing the abstract and poster presentation. Dr. Meziane-Tani received the AANEM Resident & Fellow Recognition Award for this abstract.
2. Ian Bakk, Hani Kushlaf. Sensory and cranial neuropathies caused by cutaneous T cell lymphoma. AANEM annual meeting in Austin, Texas. 10/18/2019. Mentored Dr. Bakk (PGY2 resident) during all stages of preparing the abstract and poster presentation. Dr. Bakk will receive the AANEM Resident & Fellow Recognition Award for this abstract.
3. Assia Meziane-Tani, Hani Kushlaf. Charcot-Marie-Tooth type 2N caused by a novel variant in the AARS gene. MDA Clinical & Scientific Conference in Orlando, FL. Apr 16, 2019. Mentored Dr. Mezianne (PGY2 resident) during all stages of preparing the abstract and poster presentation.
4. Davalos L, Kushlaf H. New onset of seropositive generalized myasthenia gravis following intravesical Bacille Calmette-Guerin treatment for bladder cancer: A case study. Muscle Nerve. 2019 Jan; 59(1):E1-E2. doi: 10.1002/mus.26328. Mentored Dr. Davalos (PGY3 resident) during all stages of manuscript writing which led to the publication in Muscle Nerve.
5. Long Davalos, Hani Kushlaf. Erythromelalgia and sensory neuropathy in autoimmune hepatitis: A case study. Annual AANEM meeting in Washington, DC 10/2018. Mentored Dr. Davalos (PGY3 resident) during all stages of preparing the abstract and poster presentation. Dr. Davalos received the AANEM Golseth Young
9
Investigator Runner up Award and the AANEM Resident & Fellow Recognition Award for this abstract.
6. Stefanie Wolf, Hani Kushlaf. Hereditary ATTR amyloidosis in a celiac disease patient. Annual AANEM meeting in Washington, DC 10/2018. Mentored Dr. Wolf (PGY2 resident) during all stages of preparing the abstract and poster presentation. Dr. Wolf received the AANEM Resident & Fellow Recognition Award for this abstract.
7. Chelsea Zale, Hani Kushlaf. Immunotherapy responsive Intestinal Pseudoobstruction in thymoma and myasthenia gravis: A case study. Annual AANEM meeting in Washington, DC 10/2018. Mentored Dr. Zale (PGY2 resident) during all stages of preparing the abstract and poster presentation. Dr. Zale received the AANEM Resident & Fellow Recognition Award for this abstract.
8. Lee I, Kushlaf H. Needle electromyography practice patterns in patients on novel oral anticoagulants: A survey-based study. Muscle Nerve. 2018 Aug;58(2):307-309. doi: 10.1002/mus.26119. Mentored neuromuscular medicine fellow/Ikjae Lee during all stages of preparing abstract that was presented at the annual AAN meeting and then write up a manuscript, which led to the publication in Muscle Nerve.
9. Ikjae Lee, Hani Kushlaf. Voltage-Gated Potassium Channel Autoantibody in a patient with small fiber neuropathy and parkinsonism. AANEM annual meeting in New Orleans, LA. Sept, 16, 2016- Mentored resident Ikjae Lee during all stages of preparing this abstract and poster presentation. Dr. Lee won the AANEM Junior recognition award for this poster presentation.
10. Staci King, Hani Kushlaf. A Charcot-Marie-Tooth disease type 2-like neuropathy in a 49, XXXXY male. AANEM annual meeting in Honolulu, Hawaii. Oct, 30, 2015- Mentored resident Staci King during all stages of preparing this abstract and poster presentation. Dr. King won the AANEM Junior member recognition award for this poster presentation.
11. Jaimin Shah, Hani Kushlaf. Seropositive Generalized Myasthenia Gravis Following Intravesical Bacille Calmette-Guerin Treatment for Bladder Cancer. AANEM annual meeting in Savannah, Georgia, Oct,29,2014. Mentored resident Jaimin Shah during all stages of preparing this abstract and poster presentation. Dr. Shah won the AANEM Junior member recognition award for this poster presentation.
Conferences:
Conferences during residency and NM fellowships:
1- Pediatric neurology grand rounds, a case of tick paralysis. Jun., 2007.
2- Pediatric neurology grand rounds, a case of idiopathic ataxia of childhood. Jun., 2007.
3- Neuromuscular conference, Sensory mononeuropathies. Aug, 2007.
10
4- Stroke conference, a case of vertebrobasilar insufficiency caused by surgical treatment of congenital heart disease, Feb, 2008.
5- Neurological history and examination lecture to psychiatry residents. Feb., 2008.
6- Pediatric neurology grand rounds, a review of otogenic cerebellar abscess. Apr., 2008.
7- Pediatric neurology grand rounds, a case presentation of ADEM and review of the literature. Apr., 2008
8- Neuromuscular conference, case presentation and review of familial ALS. May, 2008.
9- Case videos of eye movement disorders, Resident lecture. Jan., 2009.
10- A review of entrapment neuropathies, Resident lecture. Jan., 2009.
11- Primary non-neoplastic cysts, Resident lecture. Apr., 2009.
12-Adult neurology grand rounds at University of Kentucky (teleconnected to King Abdullah University in Jordan and Universidad federal de Sao Paulo in Brazil), Neurology and THE SKIN. Apr., 2009.
13- Inherited metabolic disorders of the nervous system, Resident lecture. June, 2009.
14- Muscle conference; Myotonic disorders (case presentation and review). Oct., 2009.
15-Muscle conference; Mitochondrial disorders (case presentation and review). Dec., 2009.
16-Muscle conference; Rhabdomyolysis and disorders of lipid metabolism in muscle (case presentation and review). Feb., 2010.
17-Muscle conference; distal myopathies (case presentation and review). Jun., 2010
18-Peripheral nerve conference; Granulomatous vasculitis presenting as painful bilateral sciatic neuropathies. Oct, 2010.
19-Peripheral nerve conference; Carcinomatous infiltration of lumbosacral nerve roots presenting as a painful mass. Dec, 2010.
20-Peripheral nerve conference; Focal CIDP presenting as a left brachial plexopathy in a patient with history of Childhood lymphoma and mantle radiation. Feb, 2011.
21- Peripheral nerve conference: Cutaneous T cell Neurolymphomatosis. June, 2011.
22- Motor nerve conduction studies. July, 2011
23-Electrodiagnostic classification of peripheral neuropathies. Aug, 2011.
24-Neuromuscular pathology conference: Case presentations, Sept,12, 2011
25-Neuromuscular pathology conference: Case presentations, Sept, 26, 2011.
11
26- Electrodiagnostic studies in myotonic disorders and periodic paralyses. Dec, 14, 2011
27- Neuromuscular pathology conference: Case presentations, Mar, 12, 2012.
28- Neuromuscular pathology conference: Case presentations, Mar, 26, 2012.
29- Neuromuscular pathology conference: Case presentations, June, 25, 2012.
Neurology residents and fellows section of The American Academy of Neurology- E-Pearl of the week:
-E-Pearl of the week: Hot and Dry foot as a sign of cancer. May, 3, 2011.
- E-Pearl of the week: Cerebral venous thrombosis as a cause of thunderclap headache. May, 14, 2009.
Neuromuscular Conferences at The University of Cincinnati:
1- Peripheral nerve ultrasound demonstration for neuromuscular faculty members at UC, 9/25/2012,10/31/2012
2- NM conference. Case presentation and review: Scapuloperoneal motor neuronopathy with CMT phenotype. 12/19/2012
3- NM conference. Case presentation and review: POEMS syndrome. 2/20/2013
4- NM conference. Case presentation and review. Autosomal dominant chronic vacuolar myopathy. 4/24/2013
5- NM conference. Neurologic thoracic outlet syndrome. Case presentation and review. 6/12/2013
6- NM conference. Anti-SRP myopathy. Case presentation and review of literature. 9/4/2013
7- NM conference. Chronic myopathy with external ophthalmoplegia. Case presentation and discussion. 10/30/2013
8- NM conference. Acute radial mononeuropathy following bariatric surgery. Case presentation and review of literature. 12/4/2013
9- NM conference, Case presentation and literature review: Diabetic muscle infarction. 1/29/2014
10- NM conference, Case presentation: Recurrent cranial neuropathies and predominantly sensory neuropathy of unknown etiology. 8/13/2014
11- NM conference, Case presentation: Gluten neuropathy. 9/23/2015
12- NM conference, Case presentation: Sensory neuropathy caused by a novel MPZ variant. 5/13/2019
12
13- NM conference, Overview of Ongoing and Upcoming Myasthenia Gravis Trials. 6/24/2019
14- NM case conference, A case of VCP myopathy. 9/23/2019
15- NM case conference, A novel laminopathy phenotype. 1/13/2020
16- NM conference, A new therapy for spinal muscular atrophy. 8/24/2020
17- NM conference. Right long thoracic mononeuropathy as a forme fruste of neuralgic amyotrophy in Behcet’s disease. 12/14/2020
5/7/2014-Present Monthly Clinical Neuromuscular Pathology conference
Neurology Resident’s Teaching Lectures:
1. Lambert-Eaton Myasthenic Syndrome. 4/23/2020
2. Inclusion body myositis. 4/7/2020
3. Interesting myopathy cases. 1/4/2019
4. Introduction to peripheral nerve and muscle pathology 7/20/2017
5. Overview of the clinical neuromuscular examination and examples of abnormal findings 7/20/2017
6. Neurology resident neuromuscular journal club. IVIG vs. PLEX in MG 4/22/2016 (Journal club)
7. Neurology resident neuromuscular journal club. IVIG vs. PLEX in GBS 4/15/2016 (Journal club)
8. Focal mononeuropathies of the lower limb. 11/28/2012
Pathology Resident’s Teaching Lectures:
1. Introduction to muscle pathology (Part 1). 11/30/2018, 8/26/2020
2. Introduction to muscle pathology (Part 2). 2/27/2019, 9/23/2020
Clinical Neurophysiology Fellowship lectures at The University of Cincinnati:
1. Single fiber EMG. 1/9/2013, 8/27/2014
2. Peripheral nerve biopsy lecture. 1/16/2013, 10/8/2014
13
Neuromuscular Medicine Fellowship lectures at The University of Cincinnati:
1. Motor nerve conduction studies. 7/8/2015, 8/25/2016
2. Introduction to peripheral nerve biopsy 8/5/2015
3. Introduction to peripheral nerve ultrasound: The machine 9/2/2015
4. EDX classification of peripheral neuropathies 9/9/2015
5. Electrodiagnostic report writing 9/16/2015, 9/30/2016
6. Electrodiagnostic billing 10/14/2015, 9/23/2016
7. Distal myopathies 11/11/2015
8. Single fiber EMG 11/18/15, 6/23/2017
9. Electrodiagnostic self-assessment videos 12/30/2015
10. Electrodiagnostic self-assessment video review 2/5/2016
11. Electrodiagnosis of non-dystrophic myotonias and periodic paralyses 2/26/2016
12. IVIG vs PLEX in GBS 4/15/2016 (Journal club)
13. IVIG vs PLEX in MG 4/22/2016 (Journal club)
14. 2016 NMSAE review session 6/10/2016
15. 2016 EDXSAE review session 6/17/2016
16. Introduction to muscle biopsies 11/18/2016
17. 2017 EDXSAE review sessions 5/26/2017, 6/2/2017
18. 2017 NMSAE review session 7/26/2017, 7/28/2017, 8/4/2017
Neurology grand rounds at The University of Cincinnati:
1. Dissecting POEMS Syndrome. 6/24/2020
2. The Complement System in Myasthenia Gravis. 5/9/2018
3. Clinical Pathological Conference (Late onset Pompe disease). 3/28/2018
4. Clinical Pathologic Conference (Familial amyloid polyneuropathy caused by TTR mutation). 5/24/2017
5. Clinical pathologic conference (SEPN1-related myopathy). 3/11/2015
14
6. Neuromuscular Ultrasound: A helpful old imaging modality. 3/19/2014
National presentations/Invited Lectures:
1. Clinical Trials Plenary Session of the 2021 American Academy of Neurology Annual Meeting “Efficacy and Safety Results of the Avalglucosidase alfa Phase 3 COMET Trial in Late-Onset Pompe Disease Patients” 4/20/2021
2. Muscular Dystrophy Association (MDA) Engage Ohio Community Education Virtual Seminar “Research and Clinical Trial Review and Updates”. 8/15/2020
3. American Association of Neuromuscular and Electrodiagnostic Medicine Workshop at the annual meeting “Myopathy: Electrodiagnostic Approach”. 10/16/2019
4. Ohio Regional Myasthenia Gravis Foundation of America (MGFA) Conference, Cleveland, OH-“Novel therapies in Myasthenia Gravis”. 10/27/2018
5. Myotonic Dystrophy Day Regional Conference at Cincinnati Children Hospital and Medical Center: Exercise and Mobility in Myotonic Dystrophy (sessions 1&2). 10/20/2018
6. The 10th annual Advances in Neurology course, University of Louisville, Department of Neurology: Clinical Approach to Myopathies. 5/19/2018
7. Neuroscience Grand rounds at Indiana University: The Neurology of POEMS Syndrome. 5/25/16
8. UC PM&R Neuromuscular Conference. A case of non-systemic vasculitic neuropathy. 4/21/2016
9. Respiratory failure in a young male caused by SEPN1 mutation. Case presentation at the Challenging NM and EDX cases conference at the annual AANEM meeting in Honolulu, HI. 10/2/2015
10. Introduction to Musculoskeletal ultrasound workshop (Part I: upper extremity) at Drake Center “Introduction to peripheral nerve ultrasound”. 6/6/2014
11. Rheumatology, Allergy, and Immunology grand rounds at The University of Cincinnati “Clinical and pathological mimickers of polymyositis”. 6/26/2013
12. Welander Distal Myopathy, case presentation at the diagnostic and management problems in neuromuscular disease conference at the AAN meeting. New Orleans, LA. Apr, 24, 2012.
13. Grand rounds, Peripheral Nerve Ultrasound: Basics and Beyond, Medical College of Wisconsin, Milwaukee, WI, April,6, 2012.
14. Case presentation of de novo RYR1 mutation at the 10th Annual Duke Advanced EMG and EMG-Chemodenervation conference. Duke University. Mar, 3, 2012
15. Seminar presentation at University of Colorado: Peripheral Nerve Ultrasound: Is it helpful? Nov, 9, 2011.
15
16. Grand rounds, Peripheral Nerve Ultrasound: From Basics to Clinical Applications, University of Kentucky, Lexington, Ky, Oct, 25, 2011.
17. Intraneural injury neuroma, case presentation at the diagnostic and management problems in neuromuscular disease conference at the AAN meeting. Honolulu, HI. Apr, 12, 2011.
18. Inclusion body myositis, a research based presentation at the American Neurological Association (ANA) annual summer course in Park City, Utah. Aug, 8, 2008
8. RESEARCH
Grants:
7/1/2018-Present Investigator, MDA Care Center grant. “148,785 K”
5/8/2017-Present Sub-Investigator, Epidural Steroid Injection with Supplemental Oral Eplerenone for Low Back Pain: A Prospective, Double Blind Randomized Trial. College of Medicine’s Research Innovation Seed Grant “30 K”
10/01/2016 - 09/30/2017 Site investigator, Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS). Patient-Centered Outcomes Research Institute (Sub Award). “62,125 K”
6/2014-6/2015 Center for Environmental Genetic- Next Generation Biomedical Investigator Award for research career development “10 K”
Protocols:
12/13/2018-Present Co-PI, Genetic Modifiers of Muscular Dystrophy and Cardiomyopathies
6/10/2020-Present PI, Patient Preference in Virtual Versus In-Person Visits in Neuromuscular Clinical Practice
Clinical Trials:
5/11/2020-Present PI, Randomized, Double-blind, Multicenter, Placebo-controlled Phase 3 Study with Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adults with Myasthenia Gravis
5/5/2020-1/19/2021 Sub-Investigator, A Phase 3, Double-Blind, Randomized, Placebo- Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Patients with Amyotrophic Lateral Sclerosis (ALS)
16
2/20/2020-Present PI, Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
2/20/2020-Present PI, A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
1/9/2020-Present PI, A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Patients with Generalized Myasthenia Gravis
1/9/2020-Present PI, A Phase 3 Open-Label Extention Study to Assess The Long-Term Safety and Efficacy of Intravenous ATB200 Co-Administered with Oral AT2221 in Adult Subjects with Late-Onset Pompe Disease.
10/23/2019-Present Sub-I, Multicenter, randomized, double-blind, parallel-group extension to study AC-058B201 to investigate the long-term safety, tolerability, and efficacy of 10, 20, and 40 mg/day ponesimod, an oral S1P1 receptor agonist, in patients with relapsing-remitting multiple sclerosis.
6/18/2019-Present PI, Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP
6/272019-9/19/2019 PI, A Long-Term, Single-Arm, Open-Label, Multicenter, Phase 3 Follow-on Trial of ARGX-113-1704 to Evaluate the Safety and Tolerability of ARGX-113 in Patients with Myasthenia Gravis having Generalized Muscle Weakness
6/18/2019-Present PI, A Open-label Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients with Generalized Myasthenia Gravis
5/8/2019-9/19/2019 PI, A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Trial to Evaluate the Efficacy, Safety and Tolerability of ARGX-113 in Patients with Myasthenia Gravis Having Generalized Muscle Weakness
4/12/2019-Present PI, An open-label, multicenter, multinational extension study of the long- term safety and pharmacokinetics of repeated biweekly infusions of neoGAA in patients with Pompe disease
2/11/2019-Present PI, A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement- Inhibitor-Naïve Adult Patients With Generalized Myasthenia Gravis
1/4/2019-3/17/2021 PI, A Phase 2, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults with Generalized Myasthenia Gravis.
12/6/2018-3/4/2021 PI, A phase 3 Double-Blind Randomized Study to Assess the Efficacy and Safety of Intravenous ATB200 CO-Administered with Oral AT2221 in Adult Subjects with Late-Onset Pompe Disease Compared with Alglucosidase Alfa/Placebo.
17
6/7/2018-Present PI, Long Term Safety Study of Amifampridine Phosphate in Patients with MuSK Antibody Positive and AChR Antibody Positive Myasthenia Gravis Patients
6/7/2018-2/8/2021 PI, A Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Amifampridine Phosphate in Patients with MuSK Antibody Positive Myasthenia Gravis, and a Sample of AChR Antibody Positive Myasthenia Gravis Patients
5/18/2017-Present PI, A Phase 3/4 Prospective Study to Characterize the Pharmacokinetics of Alglucosidase Alfa in Patients with Pompe Disease
5/8/2017-Present Sub-Investigator, Epidural Steroid Injection with Supplemental Oral Eplerenone for Low Back Pain: A Prospective, Double Blind Randomized Trial
6/8/2016-10/25/2017 PI, Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
4/28/2016-Present PI, Phase 3 randomized, multicenter, double-blinded study comparing efficacy and safety of repeated biweekly infusion of neoGAA and alglucosidase alfa in treatment-naïve patient with late onset Pompe disease.
11/2014-1/15/2019 Sub-Investigator, University of Cincinnati, Compassionate Use of 3,4- Diaminopyriding in Lambert Eaton Syndrome
1/8/2015-6/29/2018 Sub-Investigator, NeuroNEXT, NINDS funded, “A phase II Trial of Rituximab in Myasthenia Gravis”
10/2011-6/2012 Co-PI At Duke University medical center: Peripheral Nerve Ultrasound to differentiate inherited from acquired demyelinating neuropathies
Publications:
1. Jordi Diaz-Manera, Priya S. Kishnani, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar,Volker Straub, Antonio Toscano, Ans T. van der Ploeg, Kenneth I. Berger, Paula R. Clemens,Yin-Hsiu Chien, John W. Day, Sergey Illarioshikin, Mark Roberts, Shahram Attarian, Joao Lindolfo Borges, Francoise Bouhour,Young Chul Choi, Sevim ErdemOzdamar, Ozlem Goker-Alpan,Anna Kostera-Pruszczyk,Kristina An Haack, Christopher Hug, Olivier Huynh-Ba,Judith Johnson,Nathan Thibault, Tianyue Zhou, Mazen M. Dimachkie, Benedikt Schoser. Initial Results of the Avalglucosidase Alfa Phase 3 COMET Trial in Late-Onset Pompe Disease Patients. Lancet Neurology (in review).
2. Sandrone S, Albert DVF, Dunham SR, Kraker JB, Noviawaty I, Palm M, Kushlaf H. Future of Training in Neurology: How Lessons Learned on Teaching, Well-being and Telemedicine During the COVID-19 Pandemic Can Shape the Future of Neurology Education. Neurology (Accepted for publication 3/15/2021)
18
3. Bazrafshan S, Kushlaf H, Kakroo M, Quinlan J, Becker RC, Sadayappan S. Genetic Modifiers of Hereditary Neuromuscular Disorders and Cardiomyopathy. Cells. 2021 Feb 8;10(2):349. doi: 10.3390/cells10020349.
4. Kushlaf H. Immune profiling beyond antibodies in double seronegative and acetylcholine receptor antibody positive myasthenia gravis: What do we learn?. Muscle Nerve. 2021 Jan 12. doi: 10.1002/mus.27167. Online ahead of print.
5. Janecek J, Kushlaf H. Toxin-induced channelopathies, neuromuscular junction disorder, and myopathy. Neurol Clin. 2020 Nov;38(4):765-780. doi: 10.1016/j.ncl.2020.07.001
6. Kushlaf H. Cystinosis Myopathy: Searching for Optimal Clinical Outcome Measures. Muscle Nerve. 2020 Sep 22. doi: 10.1002/mus.27065. Online ahead of print.
7. Kushlaf H. COVID-19 in MuSK Myasthenia Gravis: A Case Report. Muscle Nerve. Muscle Nerve. 2020 Oct;62(4):E65-E66. doi: 10.1002/mus.27020
8. Barohn RJ, Gajewski B, Pasnoor M, Brown A, Herbelin LL, Kimminau KS, Mudaranthakam DP, Jawdat O, Dimachkie MM; and the Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN- CONTRoLS) Study Team, Iyadurai S, Stino A, Kissel J, Pascuzzi R, Brannagan T, Wicklund M, Ahmed A, Walk D, Smith G, Quan D, Heitzman D, Tobon A, Ladha S, Wolfe G, Pulley M, Hayat G, Li Y, Thaisetthawatkul P, Lewis R, Biliciler S, Sharma K, Salajegheh K, Trivedi J, Mallonee W, Burns T, Jacoby M, Bril V, Vu T, Ramchandren S, Bazant M, Austin S, Karam C, Hussain Y, Kutz C, Twydell P, Scelsa S, Kushlaf H, Wymer J, Hehir M, Kolb N, Ralph J, Barboi A, Verma N, Ahmed M, Memon A, Saperstein D, Lou JS, Swenson A, Cash T. Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial. JAMA Neurol. 2020 Aug 17. doi: 10.1001/jamaneurol.2020.2590. Online ahead of print.
9. Kushlaf, H. Diving into the heterogeneity of inclusion body myositis. Muscle Nerve. Muscle Nerve. 2020 Jul;62(1):7-9. doi: 10.1002/mus.26897
10. Kushlaf H. Peripheral neuropathy and the Ceruloplasmin Gene. Ann Intern Med. 2019 Feb 19;170(4):282. doi: 10.7326/L18-0629.
11. Kushlaf H, Li Y. The evidence is stacked against thymectomy in MuSK myasthenia gravis. Muscle Nerve. 2019 Apr;59(4):393-394. doi: 10.1002/mus.26439
12. Sandrone S, Berthaud JV, Chuquilin M, Cios J, Ghosh P, Gottlieb-Smith RJ, Kushlaf H, Mantri S, Masangkay N, Menkes DL, Nevel KS, Sarva H, Schneider LD. Neurological and neuroscience education: mitigating neurophobia to mentor health
19
care providers. Neurology. 2019 Jan 22;92(4):174-179. doi: 10.1212/WNL.0000000000006716.
13. Davalos L, Kushlaf H. New onset of seropositive generalized myasthenia gravis following intravesical Bacille Calmette-Guerin treatment for bladder cancer: A case study. Muscle Nerve. 2019 Jan;59(1):E1-E2. doi: 10.1002/mus.26328
14. Janecek J, Kushlaf H. Gordon Reflex. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.2018 Jul 7.
15. Janecek J, Kushlaf H. Bekhterev Jacobsohn Reflex. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.2018 Jul 3.
16. Lee I, Kushlaf H. Needle electromyography practice patterns in patients on novel oral anticoagulants: A survey-based study. Muscle Nerve. 2018 Aug;58(2):307-309. doi: 10.1002/mus.26119.
17. Davalos L, Kushlaf H. Abnormal electromyographic spontaneous activity. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-2018 Feb 21.
18. Kushlaf, HA, Massey EW, Hobson-Webb L. Proximal median neuropathy caused by surgical manipulation of Masson tumor. Muscle Nerve. 2014;50:617-618
19. Kushlaf, HA. Emerging Toxic Neuropathies and Myopathies. Psychiatr Clin North Am. 2013;36:209-18.
20. Erra C, Granata G, Liotta G, Podnar S, Giannini M, Kushlaf H, Hobson-Webb LD, Leversedge FJ, Martinoli C, Padua L. Ultrasound diagnosis of bony nerve entrapment: Case series and literature review. Muscle Nerve. 2013;48:445-50
21. Kushlaf, HA. Emerging Toxic Neuropathies and Myopathies, Neurol Clin. 2011;29:679-87.
Abstracts:
1. Mark Tarnopolsky, Shahram Attarian, Joao Lindolfo Borges, Francoise Bouhour, Yin-Hsiu Chien, Young-Chul Choi, Paula Clemens, John Day, Jordi Díaz-Manera, Sevim Erdem-Ozdamar, Ozlem Goker-Alpan, Sergey Illarioshkin, Priya S. Kishnani, Anna Kostera-Pruszczyk, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Mark Roberts, Volker Straub, Antonio Toscano, Ans T. van der Ploeg, Kristina An Haack, Christopher Hug, Olivier Huynh-Ba, Judith Johnson, Tianyue Zhou, Mazen Dimachkie, Benedikt Schoser; on behalf of the COMET Study Group. Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in participants with late-onset Pompe disease (LOPD). Submitted for presentation at the 2021 Canadian Neurological Sciences Federation (CNSF) Congress.
20
2. Jordi Diaz-Manera, Shahram Attarian, Joao Lindolfo Borges, Francoise Bouhour, Yin-Hsiu Chien, Young-Chul Choi, Paula R. Clemens, John W. Day, Sevim Erdem- Ozdamar, Ozlem Goker-Alpan10, Sergey Illarioshkin, Priya Kishnani, Anna Kostera- Pruszczyk, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Mark Roberts, Benedikt Schoser, Volker Straub, Antonio Toscano, Ans van der Ploeg, Kristina An Haack, Christopher Hug, Olivier Huynh-Ba, Judith Johnson, Tianyue Zhou, Mazen Dimachkie. Initial Results of the Avalglucosidase alfa Phase 3 COMET Trial in Late- Onset Pompe Disease Patients. Submitted for presentation at the ICNMD 2021 annual meeting.
3. Benedikt Schoser, Shahram Attarian, Joao Lindolfo Borges, Francoise Bouhour4, Yin-Hsiu Chien, Young-Chul Choi, Paula R. Clemens, John W. Day, Jordi Diaz- Manera, Sevim Erdem-Ozdamar, Ozlem Goker-Alpan, Sergey Illarioshkin, Priya Kishnani, Anna Kostera-Pruszczyk, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Mark Roberts, Volker Straub, Antonio Toscano, Ans van der Ploeg, Kristina An Haack, Christopher Hug, Olivier Huynh-Ba, Judith Johnson, Tianyue Zhou, and Mazen M. Dimachkie on behalf of the COMET Study Group. Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients. Accepted for oral presentation at the EAN 2021 annual meeting 6/19-22/2021.
4. Hani Kushlaf, Shahram Attarian, Joao Lindolfo Borges, Francoise Bouhour, Yin- Hsiu Chien, Young-Chul Choi, Paula Clemens, John Day, Jordi Diaz-Manera, Sevim Erdem-Ozdamar, Ozlem Goker-Alpan, Sergey Illarioshkin, Priya Kishnani, Anna Kostera-Pruszczyk, Shafeeq Ladha, Tahseen Mozaffar, Mark Roberts, Volker Straub, Antonio Toscano, Ans van der Ploeg, Kristina An Haack, Christopher Hug, Olivier Huynh-Ba, Tianyue Zhou, Judith Johnson, Mazen M. Dimachkie, and Benedikt Schoser on behalf of the COMET Study Group. Efficacy and safety of Avalglucosidase Alfa in patients with Late-Onset Pompe Disease: Results from the phase 3 COMET trial. Presented at the clinical trial plenary session at the 2021 AAN annual meeting 4/20/2021. Won merit of distinction from the AAN (Top abstract in its topic category in quality of study and interest to the neurologic community).
5. Ian Bakk, Hani Kushlaf. Sensory and cranial neuropathies caused by cutaneous T cell lymphoma. UCGNI/NRC Neuroscience research day 4/6/2021.
6. Hani Kushlaf. Myopathy predominant presentation caused by the c.1360 C>T desmin pathogenic variant. UCGNI/NRC Neuroscience research day 4/6/2021.
7. Hani Kushlaf. Long thoracic mononeuropathy as a forme fruste of neuralgic amyotrophy in Behcet’s disease. UCGNI/NRC Neuroscience research day 4/6/2021.
8. Priya Kishnani, Shahram Attarian, Joao Lindolfo Borges, Francoise Bouhour, Yin- Hsiu Chien, Young-Chul Choi, Paula Clemens, John Day, Jordi Diaz Manera, Mazen
21
Dimachkie, Sevim Erdem-Ozdamar, Ozlem Goker-Alpan, Sergy Illarioshkin, Anna Kostera-Pruszczyk, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Mark Roberts, Benedikt Schoser, Volker Straub, Antonio Toscano, Ans van der Ploeg, Kristina An Haack, Christopher Hug, Olivier Huynh-Ba, Judith Johnson. Efficacy and safety of Avalglucosidase Alfa in patients with Late-Onset Pompe Disease: Results from the phase 3 COMET trial. Accept for presentation at World 2021 meeting (2/8-11, 2021).
9. Mazen Dimachkie, Shahram Attarian, Joao Lindolfo Borges, Francoise Bouhour, Yin- Hsiu Chien, Young-Chul Choi, Paula Clemens, John Day, Jordi Diaz Manera, Sevim Erdem-Ozdamar, Ozlem Goker-Alpan, Sergy Illarioshkin, Priya Kishnani, Anna Kostera-Pruszczyk, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Mark Roberts, Benedikt Schoser, Volker Straub, Antonio Toscano, Ans van der Ploeg, Kristina An Haack, Christopher Hug, Olivier Huynh-Ba, Judith Johnson, on behalf of the COMET Study Group. Efficacy and safety of Avalglucosidase Alfa in patients with Late-Onset Pompe Disease: Results from the phase 3 COMET trial. AANEM annual meeting (virtual). 10/8/2020.
10. Jacqueline Janecek, Hani Kushlaf. Myopathy predominant presentation caused by the c.1360 C>T desmin pathogenic variant. AANEM annual meeting (virtual). 10/8/2020.
11. Paula Clemens, Shahram Attarian, Joao Lindolfo Borges, Francoise Bouhour, Yin- Hsiu Chien, Young-Chul Choi, John Day, Jordi Diaz Manera, Mazen Dimachkie, Sevim Erdem-Ozdamar, Ozlem Goker-Alpan, Sergy Illarioshkin, Priya Kishnani, Anna Kostera-Pruszczyk, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Mark Roberts, Benedikt Schoser, Volker Straub, Antonio Toscano, Ans van der Ploeg, Kristina An Haack, Christopher Hug, Olivier Huynh-Ba, Judith Johnson, Keijan Liu. Efficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease: results from the phase 3 COMET trial. World Muscle Society (WMS) annual meeting (virtual). 10/1/2020
12. Assia Meziane-Tani, Hani Kushlaf. Axonal Charcot-Marie-Tooth disease caused by a novel YARS variant. AANEM annual meeting in Austin, Texas. 10/18/2019.
13. Ian Bakk, Hani Kushlaf. Sensory and cranial neuropathies caused by cutaneous T cell lymphoma. AANEM annual meeting in Austin, Texas. 10/18/2019.
14. Sholeh Kondori, Hani Kushlaf, Roman Jandarov, Richard Becker, Sakthival Sadayappan. Genetic Modifiers of Muscular Dystrophy and Cardiomyopathies. Cincinnati Children's Heart Retreat in Cincinnati, OH. 10/7/2019
15. Hani Kushlaf. A Novel Myelin Protein Zero variant in Charcot-Marie-Tooth Disease Type 2I. American Academy of Neurology (AAN) annual meeting Philadelphia, PA. May, 7, 2019.
22
16. Assia Meziane-Tani, Hani Kushlaf. Charcot-Marie-Tooth type 2N caused by a novel variant in the AARS gene. MDA Clinical & Scientific Conference in Orlando, FL. Apr 16, 2019
17. Jacqueline Janecek, Hani Kushlaf. Rapid and sustained improvement with eculizumab in anti-AchR antibody myasthenia gravis. University of Cincinnati Gardner Neurosicence Institute (UCGNI) research day. Apr 16, 2019
18. Sandrone S, Berthaud JV, Chuquilin M, Cios J, Ghosh P, Gottlieb-Smith RJ, Kushlaf H, Mantri S, Masangkay N, Menkes DL, Nevel KS, Sarva H, Schneider LD. Neurological and neuroscience education: mitigating neurophobia to mentor health care providers. AAN annual meeting. Philadelphia, PA. May, 5, 2019.
19. Sholeh Kondori, Roman Jandarov, Kamal Kassem, Hani Kushlaf, Richard Becker, Sakthival Sadayappan. Genetic Modifiers of Muscular Dystrophy and Cardiomyopathies. UC Internal Medicine Symposium. Apr, 5, 2019.
20. Jacqueline Janecek, Hani Kushlaf. Rapid and sustained improvement with eculizumab in anti-AchR antibody myasthenia gravis. MGFA’s Annual Scientific Session on Myasthenia Gravis at the American Association of Neuromuscular and Electrodiagnostic Medicine in Washington, DC. 10/10/2018.
21. Long Davalos, Hani Kushlaf. Erythromelalgia and sensory neuropathy in autoimmune hepatitis: A case study. American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) annual meeting in Washington, DC. 10/2018.
22. Stefanie Wolf, Hani Kushlaf. Hereditary ATTR amyloidosis in a celiac disease patient. AANEM annual meeting in Washington, DC. 10/2018.
23. Chelsea Zale, Hani Kushlaf. Immunotherapy responsive Intestinal Pseudoobstruction in thymoma and myasthenia gravis: A case study. AANEM annual meeting in Washington, DC. 10/2018.
24. Hani Kushlaf. Lamotrigine for rhabdomyolysis and myotonia in G1306A mutation of the SCN4A gene: A case study. AANEM annual meeting in Washington, DC. 10/2018.
25. Chelsea Zale, Hani Kushlaf. Immunotherapy responsive Intestinal Pseudoobstruction in thymoma and myasthenia gravis: A case study. University of Cincinnati Gardner Neuroscience Institute (UCGNI) research day. Apr 17, 2018
26. Long Davalos, Hani Kushlaf. Erythromelalgia and sensory neuropathy in autoimmune hepatitis: A case study. UCGNI research day. Apr 17, 2018
23
27. Hani Kushlaf. Rhabdomyolysis and myotonia in G1306A mutation of the SCN4A gene: A case study. UCGNI research day. Apr 17, 2018
28. Stefanie Wolf, Hani Kushlaf. Hereditary ATTR amyloidosis in a celiac disease patient. UCGNI research day. Apr 17, 2018
29. Hani Kushlaf. Rhabdomyolysis and myotonia in G1306A mutation of the SCN4A gene: A case study. MDA annual meeting in Arlington, VA. Mar, 13, 2018.
30. Hani Kushlaf, John Quinlan. A novel chloride DNA variant producing pregnancy- induced myotonia. AANEM annual meeting in Phoenix, AZ. Sept, 14, 2017
31. Hani Kushlaf. Acute unilateral hypoglossal palsy as a result of compression by the posterior inferior cerebellar artery. AANEM annual meeting in Phoenix, AZ. Sept, 15, 2017
32. Barohn RJ, Gajewski B, Pasnoor M, Brown L, Herbelin L, Kimminau K, Jawdat O, Parks C, Shlemon P, Dimachkie MM, and the PAIN-CONTRoLs Study Team. Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situation (PAIN-CONTRoLS). Peripheral nerve Society meeting in Barcelona, Spain. 7/2017.
33. Russell Sawyer, Ashby Turner, Hani Kushlaf. Motor neuronopathy in Leber hereditary optic neuropathy due to mt.14484 T>C mutation. AAN annual meeting Boston, MA. April 25, 2017.
34. Hani Kushlaf, John Quinlan. A novel chloride DNA variant producing pregnancy- induced myotonia. UCGNI research day. Apr 18, 2017.
35. Hani Kushlaf. Severe axial weakness in anoctaminopathy. AANEM annual meeting in New Orleans, LA. Sept, 16, 2016
36. Ikjae Lee, Hani Kushlaf. Voltage-Gated Potassium Channel Autoantibody in a patient with small fiber neuropathy and parkinsonism. AANEM annual meeting in New Orleans, LA. Sept, 16, 2016
37. Ikjae Lee, Hani Kushlaf. Needle electromyography practice pattern in patients taking novel oral anticoagulants: A survey-based study. AAN annual meeting Vancouver, Canada. April, 16, 2016.
38. Nassima Baba-Ahmed, Aram Zabeti, Hani Kushlaf. Hereditary Neuropathy with Liability to Pressure Palsies (HNPP) and Multiple Sclerosis (MS) in the Same Patient: Coincidence or Link? .AAN annual meeting Vancouver, Canada. April, 17, 2016.
39. Hani Kushlaf. Electrical myotonia is not uncommon in cystinosis myopathy. AANEM annual meeting in Honolulu, Hawaii. Oct, 30, 2015.
40. Hani Kushlaf. A congenital cord-rod myopathy caused by SEPN1 mutation. AANEM annual meeting in Honolulu, Hawaii. Oct, 30, 2015.
24
41. Staci King, Hani Kushlaf. A Charcot-Marie-Tooth disease type 2-like neuropathy in a 49, XXXXY male. AANEM annual meeting in Honolulu, Hawaii. Oct, 30, 2015.
42. Daniel Smith, Hani Kushlaf. Cystinosis associated cerebral vasculopathy masquerading as atypical migraine headache. AAN annual meeting in Washington, D.C. April, 21, 2015.
43. Jaimin Shah, Hani Kushlaf. Seropositive Generalized Myasthenia Gravis Following Intravesical Bacille Calmette-Guerin Treatment for Bladder Cancer. AANEM annual meeting in Savannah, Georgia, Oct, 29,2014.
44. Julia Zhu, Hani Kushlaf. Camptocormia as the Initial Prominent Manifestation of Myotonic Dystrophy Type I. MDA Clinical Conference in Chicago, IL. Mar 16-19, 2014.
45. David Clark, Hani Kushlaf. Macroglossia in Duchenne Muscular Dystrophy. AANEM annual meeting in San Antonio, Texas. Oct,16, 2013.
46. Hani Kushlaf, Vern Juel, Lisa Hobson-Webb. Upper Extremity Peripheral Nerve Ultrasound Shows Proximal to Distal Tapering of Nerves in Demyelinating Charcot- Marie-Tooth Disease but not in Inflammatory Demyelinating Neuropathies. AAN annual meeting Mar,18,2013-Chosen for poster discussion session. San Diego, CA.
47. Hani Kushlaf, Vern Juel, Lisa Hobson-Webb. Do ultrasound characteristics correlate with electrodiagnostic findings in inflammatory neuropathies? AANEM Annual Meeting Oct,3, 2012. Orlando, FL.
48. Hani Kushlaf, Vern Juel, Lisa Hobson-Webb. Sonographically-measured nerve size and intra-nerve size variability in inflammatory polyneueropathy. AANEM Annual Meeting Oct,3, 2012. Orlando, FL.
49. Jonas Vanags, Hani Kushlaf, Vern Juel. Post-irradiation hypoglossal and accessory neuropathies with myokymic discharges. North Carolina Neurological society annual meeting, Feb 17, 2012.
Book Chapters:
1. Kushlaf, HA. Toxic myopathies (pp159-174) in Michael Dobbs, Clinical Neurotoxicology: Substances, Syndromes, Environments, Elsevier, 2009.